In systemically untreated breast cancer patients, CD4+ T cells were found to be the principal component of the tumor infiltrating lymphocytes (TIL) and along with TH1, TH2 and TH17 subtypes, were also enriched for Tfh populations (46). This evidence concerns the gene CD4 and neoplasm.